Literature DB >> 16110806

Aspergillus polymerase chain reaction (PCR) diagnosis.

D Buchheidt1, M Hummel.   

Abstract

In recent years novel molecular methods, notably polymerase chain reaction (PCR) assays, have been developed to improve the diagnosis of life-threatening invasive aspergillosis in patients at high risk, especially patients with malignant hematological disease. Early diagnosis and treatment are essential for adequate therapeutic management. Management, however, often remains difficult since most of the diagnostic tools used clinically at present either lack specificity or acceptable sensitivity. The clinical value, advantages and remaining problems of PCR approaches to detect the emerging fungal pathogen are reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110806     DOI: 10.1080/13693780500051596

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  4 in total

1.  Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay.

Authors:  M Hummel; B Spiess; K Kentouche; S Niggemann; C Böhm; S Reuter; M Kiehl; H Mörz; R Hehlmann; D Buchheidt
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

2.  A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections.

Authors:  P Lewis White; Richard Barton; Malcolm Guiver; Christopher J Linton; Steve Wilson; Melvyn Smith; Beatriz L Gomez; Michael J Carr; Patrick T Kimmitt; Shila Seaton; Kumar Rajakumar; Tessa Holyoake; Chris C Kibbler; Elizabeth Johnson; Richard P Hobson; Brian Jones; Rosemary A Barnes
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

3.  DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Wolfgang Seifarth; Margit Hummel; Oliver Frank; Alice Fabarius; Chun Zheng; Handan Mörz; Rüdiger Hehlmann; Dieter Buchheidt
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

4.  Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients.

Authors:  Markéta Marková; Helena Brodská; Karin Malíčková; Veronika Válková; Petr Cetkovský; Michal Kolář; Martin Haluzík
Journal:  Support Care Cancer       Date:  2013-05-28       Impact factor: 3.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.